BiotechTubeBiotechTube
Home/Collegium Pharmaceutical/Scott Dreyer
SD

Scott Dreyer

Executive Vice President, Chief Commercial Officer

Collegium Pharmaceutical

Therapeutic Areas

Pain ManagementNeuropsychiatryADHD

Collegium Pharmaceutical Pipeline

DrugIndicationPhase
Portfolio of Pain ProductsSevere and persistent painApproved/Commercial
JORNAY PMAttention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial
AZSTARYSAttention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial

Leadership Team at Collegium Pharmaceutical

VK
Vikram Karnani
President & Chief Executive Officer
DD
David Dieter
Executive Vice President, General Counsel
JG
Jane Gonnerman
Executive Vice President, Strategy & Corporate Development
DJ
Dean J. Patras
Chief People Officer
CT
Colleen Tupper
Executive Vice President, Chief Financial Officer
TS
Thomas Smith, M.D.
Executive Vice President, Chief Medical Officer
SS
Scott Sudduth
Executive Vice President, Head of Technical Operations
GS
Gino Santini
Chairman of the Board
RB
Rita Balice-Gordon, Ph.D.
Director
GB
Garen Bohlin
Director
View full Collegium Pharmaceutical profile